Twice-daily dosing of loracarbef 200 mg versus 400 mg in the treatment of patients with acute maxillary sinusitis

Authors: Zeckel M.L.1; Johns D.; Masica D.N.; Farlow D.

Source: Clinical Therapeutics, Volume 17, Number 2, March 1995 , pp. 214-230(17)

Publisher: Elsevier

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Language: English

Document Type: Research article

DOI: 10.1016/0149-2918(95)80020-4

Affiliations: 1: Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, U.S.A.

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A